You are viewing the site in preview mode

Skip to main content

Table 2 Clinical outcomes at W8 compared to D0

From: Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study

Outcome D0 W8 p value
Vaginal mucosa thickness (N = 19)
Superficial
 Median 28.41 26.36 p = 1
 IQR 17.31; 38.78 21.5; 35.89  
 Range 10.13; 116.88 10.6; 102.12  
Intermediate    
 Median 114.4 112.5 p = 0.6507
 IQR 85.58; 141.74 71.76; 162.12  
 Range 40.6; 230.53 36.19; 237.26  
Basal    
 Median 70.28 83.25 p = 0.8596
 IQR 59.1; 103.79 63.78; 89.77  
 Range 36.61; 128.23 36.69; 116.96  
Total    
 Median 213.65 212.33 p = 0.5949
 IQR 139.33; 300.76 175.09; 261.58  
 Range 97.66; 439.7 86.65; 456.33  
Vaginal Flora (N = 11)
Nugent score    
 Median 5 5 p = 0.5469
 IQR 3; 7 3; 5  
 Range 2; 8 1; 7  
Vaginal pH    
Vicinity of the injected area (N17)    
 Median 6 5.5 p = 0.0574
 IQR 5.5; 6.5 5; 6  
 Range 5; 7.5 4.5; 7  
Lateral vaginal pouch (N = 19)    
 Median 6 5.5 p = 0.0955
 IQR 5.5; 7 4.5; 6.5  
 Range 4; 7.5 4.5; 7.5  
Bachman VHI (N = 18)
VHI    
 Median 12 21 p < 0.0001
 IQR 10; 16 17; 22  
 Range 5; 17 12; 25  
Procollagen I and III proteins mean fluorescence intensity/μm2 (N = 19)
Procollagen I mean fluorescence intensity/μm2
 Median 47.87 61.91 p = 0.9843
 IQR 35; 72.71 27.3; 82.78  
 Range 16.06; 146.87 8.01; 145  
Procollagen III mean fluorescence intensity/μm2
 Median 11.99 10.49 p = 0.7086
 IQR 3.32; 27.36 4.6; 20.71  
 Range 0.27; 72.27 0.7; 60.13  
COL1A1 and COL3A1 gene expression N = 19
COL1A1/GAPDH
 Median 0.0035 0.0168 p = 0.0002
 IQR 0.0014; 0.0053 0.0091; 0.0403  
 Range 0.0006; 0.0151 0.0012; 0.1178  
COL3A1/GAPDH
 Median 0.0003 0.0009 p = 0.0010
 IQR 0.0002; 0.0005 0.0004; 0.0025  
 Range 0.0001; 0.0012 0.0001; 0.0068  
Mitotic activity of the mucosa (Ki67) N = 19
Ki67 positive nucleus mean/mm2
 Median 229.4 195.09 p = 0.8288
 IQR 114.54; 426.16 76.76; 463.05  
 Range 5.4; 695.26 0; 668.75